Antidiabetic, antihypertensive and statin medication use in metabolic syndrome

Butkowski, Eugene; Brix, L; Al-Aubaidy, Hayder; Kiat, H; Jelinek, H

doi:10.26181/602df5b3e1364

Antidiabetic, antihypertensive and statin medication use in metabolic syndrome

journal contribution

posted on 2021-02-18, 05:05 authored by Eugene ButkowskiEugene Butkowski, L Brix, Hayder Al-AubaidyHayder Al-Aubaidy, H Kiat, H Jelinek

Metabolic syndrome (MetS) is characterised by a cluster of metabolic risk factors, which eventually increases the risk of diabetes and cardiovascular disease (CVD). The aim of the current study was to investigate medication use in outpatient communities with respect to the occurrence of these metabolic risk factors as defined by ATPIII.

History

Publication Date

2016-04-01

Journal

International Journal of Pharmaceutical Sciences and Developmental Reseach

Volume

2

Issue

1

Pagination

6p. (p. 6-11)

Publisher

Perteez

ISSN

2640-7760

Rights Statement

The Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.